Literature DB >> 21560526

Percutaneous liver biopsy.

Tarun Rustagi1, Eric Newton, Premashish Kar.   

Abstract

Percutaneous liver biopsy has been performed for more than 120 years, and remains an important diagnostic procedure for the management of hepatobiliary disorders. Modern biochemical, immunologic, and radiographic techniques have facilitated the diagnosis and management of liver diseases but have not made liver biopsy obsolete. This comprehensive review article will discuss the history of development of percutaneous liver biopsy, its indications, contraindications, complications and the various aspects of the biopsy procedure in detail.

Entities:  

Mesh：

Year:  2010        PMID： 21560526

Source DB:  PubMed          Journal:  Trop Gastroenterol        ISSN： 0250-636X


  7 in total

1.  Evaluation of Risk Factors for Bleeding After Ultrasound-Guided Liver Biopsy.

Authors:  Haoyu Jing; Zhanxiong Yi; Enhui He; Ruifang Xu; Xianquan Shi; Li Li; Liying Sun; Ying Liu; Liang Zhang; Linxue Qian
Journal:  Int J Gen Med       Date:  2021-09-11

2.  Liver macrophage-associated inflammation correlates with SIV burden and is substantially reduced following cART.

Authors:  Bridget S Fisher; Richard R Green; Rachel R Brown; Matthew P Wood; Tiffany Hensley-McBain; Cole Fisher; Jean Chang; Andrew D Miller; William J Bosche; Jeffrey D Lifson; Maud Mavigner; Charlene J Miller; Michael Gale; Guido Silvestri; Ann Chahroudi; Nichole R Klatt; Donald L Sodora
Journal:  PLoS Pathog       Date:  2018-02-21       Impact factor: 6.823

3.  Evaluation of liver fibrosis in chronic hepatitis B patients with 2D shear wave elastography with propagation map guidance: a single-centre study.

Authors:  Seyhmus Kavak; Safak Kaya; Ayhan Senol; Nilgun Sogutcu
Journal:  BMC Med Imaging       Date:  2022-03-18       Impact factor: 1.930

4.  A single-center experience: Liver biopsy results during a year.

Authors:  Cenk Emre Meral; Genco Gencdal; Murat Akyildiz; Fulya Gunsar; Deniz Nart; Funda Yilmaz; Zeki Karasu; Galip Ersoz; Ulus Salih Akarca
Journal:  Hepatol Forum       Date:  2022-04-26

5.  Application of alkaline phosphatase‑to‑platelet ratio as a novel noninvasive index predicts liver fibrosis in patients with chronic hepatitis B.

Authors:  Ying Pan; Kai Yang; Beibei Sun; Jin Chen; Pingping Tian
Journal:  Exp Ther Med       Date:  2022-08-09       Impact factor: 2.751

6.  Value-assessment of computer-assisted navigation strategies during percutaneous needle placement.

Authors:  Imke Boekestijn; Samaneh Azargoshasb; Matthias N van Oosterom; Leon J Slof; Petra Dibbets-Schneider; Jenny Dankelman; Arian R van Erkel; Daphne D D Rietbergen; Fijs W B van Leeuwen
Journal:  Int J Comput Assist Radiol Surg       Date:  2022-08-07       Impact factor: 3.421

7.  Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C.

Authors:  Taisa Grotta Ragazzo; Denise Paranagua-Vezozzo; Fabiana Roberto Lima; Daniel Ferraz de Campos Mazo; Mário Guimarães Pessoa; Claudia Pinto Oliveira; Venancio Avancini Ferreira Alves; Flair José Carrilho
Journal:  Clinics (Sao Paulo)       Date:  2017-10       Impact factor: 2.365
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.